Emergence of Novel Mineralocorticoid Receptor Antagonists in the Age of FIGARO and FIDELIO | American Diabetes Association

Emergence of Novel Mineralocorticoid Receptor Antagonists in the Age of FIGARO and FIDELIO

Speaker: Peter Rossing
Session: Joint ADA/ASN Symposium—Cardiovascular and Renal Protection in Diabetes—Beyond SGLT2 Inhibitors and GLP-1 Receptor Agonists
Congress: 79th Scientific Sessions